1-2 of 2
Masakatsu Nishikawa, MD, PhD
Close
Sort by
Journal Articles

Dose-Adjusted (DA) - EPOCH-R with High-Dose Methotrexate for Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma (CD5+ DLBCL): Interim Results from a Phase II Study

Kana Miyazaki, MD PhD, Naoko Asano, MD PhD, Tomomi Yamada, PhD, Hirotaka Takasaki, MD PhD, Tadahiko Igarashi, MD PhD, Momoko Nishikori, MD PhD, Kinya Ohata, MD PhD, Kazutaka Sunami, MD PhD, Isao Yoshida, MD PhD, Nozomi Niitsu, MD PhD, Masataka Okamoto, MD PhD, Hiroki Yano, MD PhD, Yuki Nishimura, PhD, Satoshi Tamaru, MD PhD, Koji Izutsu, MD PhD, Tomohiro Kinoshita, MD PhD, Junji Suzumiya, MD PhD, Masakatsu Nishikawa, MD PhD, Naoyuki Katayama, MD PhD, Motoko Yamaguchi, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3029.
https://doi.org/10.1182/blood.V128.22.3029.3029
Published: 2016
Journal Articles

Rituximab As Second-Line Treatment For Chronic Immune Thrombocytopenia: Investigator-Initiated Clinical Trial In Japan

Yoshitaka Miyakawa, MD, PhD, Shinya Katsutani, MD, PhD, Takahiro Yano, MD, PhD, Shosaku Nomura, MD, PhD, Kaichi Nishiwaki, MD, Yoshiaki Tomiyama, MD, PhD, Masaaki Higashihara, MD, PhD, Yukari Shirasugi, MD, PhD, Masakatsu Nishikawa, MD, PhD, Katsutoshi Ozaki, MD, PhD, Kayoko Kikuchi, Takayuki Abe, PhD, Yuji Sato, MD, PhD, Yuzuru Kanakura, Kingo Fujimura, MD, PhD, Yasuo Ikeda, MD, PhD, Shinichiro Okamoto, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3554.
https://doi.org/10.1182/blood.V122.21.3554.3554
Published: 2013